Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”.

Teva beat fourth-quarter estimates as drug sales surged, led by Austedo and Ajovy, while the company forecast steady earnings ...

Teva Pharmaceutical Industries has seen its fair value estimate move from about US$35.32 to about US$36.77, with analysts ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this ...

Under CEO Richard Francis’ “Pivot to Growth” strategy, Teva Pharmaceutical Industries has undergone a significant ...

A jury in Atlanta federal court has sided with Teva Pharmaceuticals in the first trial testing claims the company failed to ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the cheap hot stocks to invest in right now. On January 30, Barclays analyst Glen Santangelo raised the price target for Teva ...

The drugmaker has recruited Will Forte, who appeared on “SNL” for nearly a decade in the aughts, perhaps most memorably as ...

Teva (TEVA) stock dips as the company, with its Q4 2025 results, projects a revenue drop for this year. Read more here.

"This agreement reflects our shared responsibility to support people living with MS," said Dimitri Gitas, Country President, Novartis Canada "Through this partnership, we're strengthening support for ...

Israeli drugmaker Teva Pharmaceutical Industries has presented its annual results for 2025, heralding three consecutive years ...

Teva Pharmaceutical Industries ( TEVA) shares snapped six straight sessions of gains, as the stock closed 0.4% lower at ...